Cargando…

Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae

OBJECTIVE: The risks of excess sugar intake in addition to high-fat diet consumption on immunopathogenesis of obesity-associated metabolic diseases are poorly defined. Interleukin-4 (IL-4) and IL-13 signaling via IL-4Rα regulates adipose tissue lipolysis, insulin sensitivity, and liver fibrosis in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Damen, Michelle S. M. A., Stankiewicz, Traci E., Park, Se-Hyung, Helsley, Robert N., Chan, Calvin C., Moreno-Fernandez, Maria E., Doll, Jessica R., Szabo, Sara, Herbert, De’Broski R., Softic, Samir, Divanovic, Senad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528699/
https://www.ncbi.nlm.nih.gov/pubmed/34302121
http://dx.doi.org/10.1038/s41366-021-00902-6
_version_ 1784586303880298496
author Damen, Michelle S. M. A.
Stankiewicz, Traci E.
Park, Se-Hyung
Helsley, Robert N.
Chan, Calvin C.
Moreno-Fernandez, Maria E.
Doll, Jessica R.
Szabo, Sara
Herbert, De’Broski R.
Softic, Samir
Divanovic, Senad
author_facet Damen, Michelle S. M. A.
Stankiewicz, Traci E.
Park, Se-Hyung
Helsley, Robert N.
Chan, Calvin C.
Moreno-Fernandez, Maria E.
Doll, Jessica R.
Szabo, Sara
Herbert, De’Broski R.
Softic, Samir
Divanovic, Senad
author_sort Damen, Michelle S. M. A.
collection PubMed
description OBJECTIVE: The risks of excess sugar intake in addition to high-fat diet consumption on immunopathogenesis of obesity-associated metabolic diseases are poorly defined. Interleukin-4 (IL-4) and IL-13 signaling via IL-4Rα regulates adipose tissue lipolysis, insulin sensitivity, and liver fibrosis in obesity. However, the contribution of IL-4Rα to sugar rich diet-driven obesity and metabolic sequelae remains unknown. METHODS: WT, IL-4Rα-deficient (IL-4Rα(−/−)) and STAT6-deficient mice (STAT6(−/−)) male mice were fed low-fat chow, high fat (HF) or HF plus high carbohydrate (HC/fructose) diet (HF + HC). Analysis included quantification of: (i) body weight, adiposity, energy expenditure, fructose metabolism, fatty acid oxidation/synthesis, glucose dysmetabolism and hepatocellular damage; (ii) the contribution of the hematopoietic or non-hematopoietic IL-4Rα expression; and (iii) the relevance of IL-4Rα downstream canonical STAT6 signaling pathway in this setting. RESULTS: We show that IL-4Rα regulated HF + HC diet-driven weight gain, whole body adiposity, adipose tissue inflammatory gene expression, energy expenditure, locomotor activity, glucose metabolism, hepatic steatosis, hepatic inflammatory gene expression and hepatocellular damage. These effects were potentially, and in part, dependent on non-hematopoietic IL-4Rα expression but were independent of direct STAT6 activation. Mechanistically, hepatic ketohexokinase-A and C expression was dependent on IL-4Rα, as it was reduced in IL-4Rα-deficient mice. KHK activity was also affected by HF + HC dietary challenge. Further, reduced expression/activity of KHK in IL-4Rα mice had a significant effect on fatty acid oxidation and fatty acid synthesis pathways. CONCLUSION: Our findings highlight potential contribution of non-hematopoietic IL-4Rα activation of a non-canonical signaling pathway that regulates the HF + HC diet-driven induction of obesity and severity of obesity-associated sequelae.
format Online
Article
Text
id pubmed-8528699
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85286992021-11-04 Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae Damen, Michelle S. M. A. Stankiewicz, Traci E. Park, Se-Hyung Helsley, Robert N. Chan, Calvin C. Moreno-Fernandez, Maria E. Doll, Jessica R. Szabo, Sara Herbert, De’Broski R. Softic, Samir Divanovic, Senad Int J Obes (Lond) Article OBJECTIVE: The risks of excess sugar intake in addition to high-fat diet consumption on immunopathogenesis of obesity-associated metabolic diseases are poorly defined. Interleukin-4 (IL-4) and IL-13 signaling via IL-4Rα regulates adipose tissue lipolysis, insulin sensitivity, and liver fibrosis in obesity. However, the contribution of IL-4Rα to sugar rich diet-driven obesity and metabolic sequelae remains unknown. METHODS: WT, IL-4Rα-deficient (IL-4Rα(−/−)) and STAT6-deficient mice (STAT6(−/−)) male mice were fed low-fat chow, high fat (HF) or HF plus high carbohydrate (HC/fructose) diet (HF + HC). Analysis included quantification of: (i) body weight, adiposity, energy expenditure, fructose metabolism, fatty acid oxidation/synthesis, glucose dysmetabolism and hepatocellular damage; (ii) the contribution of the hematopoietic or non-hematopoietic IL-4Rα expression; and (iii) the relevance of IL-4Rα downstream canonical STAT6 signaling pathway in this setting. RESULTS: We show that IL-4Rα regulated HF + HC diet-driven weight gain, whole body adiposity, adipose tissue inflammatory gene expression, energy expenditure, locomotor activity, glucose metabolism, hepatic steatosis, hepatic inflammatory gene expression and hepatocellular damage. These effects were potentially, and in part, dependent on non-hematopoietic IL-4Rα expression but were independent of direct STAT6 activation. Mechanistically, hepatic ketohexokinase-A and C expression was dependent on IL-4Rα, as it was reduced in IL-4Rα-deficient mice. KHK activity was also affected by HF + HC dietary challenge. Further, reduced expression/activity of KHK in IL-4Rα mice had a significant effect on fatty acid oxidation and fatty acid synthesis pathways. CONCLUSION: Our findings highlight potential contribution of non-hematopoietic IL-4Rα activation of a non-canonical signaling pathway that regulates the HF + HC diet-driven induction of obesity and severity of obesity-associated sequelae. Nature Publishing Group UK 2021-07-23 2021 /pmc/articles/PMC8528699/ /pubmed/34302121 http://dx.doi.org/10.1038/s41366-021-00902-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Damen, Michelle S. M. A.
Stankiewicz, Traci E.
Park, Se-Hyung
Helsley, Robert N.
Chan, Calvin C.
Moreno-Fernandez, Maria E.
Doll, Jessica R.
Szabo, Sara
Herbert, De’Broski R.
Softic, Samir
Divanovic, Senad
Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae
title Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae
title_full Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae
title_fullStr Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae
title_full_unstemmed Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae
title_short Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae
title_sort non-hematopoietic il-4rα expression contributes to fructose-driven obesity and metabolic sequelae
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528699/
https://www.ncbi.nlm.nih.gov/pubmed/34302121
http://dx.doi.org/10.1038/s41366-021-00902-6
work_keys_str_mv AT damenmichellesma nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT stankiewicztracie nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT parksehyung nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT helsleyrobertn nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT chancalvinc nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT morenofernandezmariae nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT dolljessicar nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT szabosara nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT herbertdebroskir nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT softicsamir nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae
AT divanovicsenad nonhematopoieticil4raexpressioncontributestofructosedrivenobesityandmetabolicsequelae